Related Experiment Video
Updated: Apr 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
UCP2 knockout suppresses mouse skin carcinogenesis
Wenjuan Li1, Chunjing Zhang2, Kasey Jackson3
1Department of Pharmacology, Toxicology and Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, Louisiana. School of Basic Medicine, Hebei University, Baoding, Hebei, China.
Abstract:
Mitochondrial uncoupling (uncouples electron transport from ATP production) has recently been proposed as a novel survival mechanism for cancer cells, and reduction in free radical generation is the accepted mechanism of action. However, there is no direct evidence supporting that uncoupling proteins promote carcinogenesis. Herein, we examined whether mitochondrial uncoupling affects mouse skin carcinogenesis using uncoupling protein 2 (UCP2) homozygous knockout and wild-type mice. The results indicate that knockout of Ucp2 significantly reduced the formation of both benign (papilloma) and malignant (squamous cell carcinoma) tumors. UCP2 knockout did not cause increases in apoptosis during skin carcinogenesis. The rates of oxygen consumption were decreased only in the carcinogen-treated UCP2 knockout mice, whereas glycolysis was increased only in the carcinogen-treated wild-type mice. Finally, the levels of metabolites pyruvate, malate, and succinate showed different trends after carcinogen treatments between the wild-type and UCP2 knockout mice. Our study is the first to demonstrate that Ucp2 knockout suppresses carcinogenesis in vivo. Together with early studies showing that UCP2 is overexpressed in a number of human cancers, UCP2 could be a potential target for cancer prevention and/or therapy. Cancer Prev Res; 8(6); 487-91. ©2015 AACR.
Insights
Mitochondrial uncoupling protein 2 (UCP2) promotes cancer. Knocking out UCP2 in mice significantly reduced tumor formation, suggesting UCP2 is a potential target for cancer prevention and therapy.
Area of Science:
- Biochemistry
- Oncology
- Mitochondrial Biology
Background:
- Mitochondrial uncoupling is proposed as a cancer cell survival mechanism.
- The exact role of uncoupling proteins in carcinogenesis is not well understood.
- Uncoupling protein 2 (UCP2) is overexpressed in several human cancers.
Purpose of the Study:
- To investigate the role of mitochondrial uncoupling protein 2 (UCP2) in mouse skin carcinogenesis.
- To determine if UCP2 knockout affects tumor formation and related cellular processes.
Main Methods:
- Utilized uncoupling protein 2 (UCP2) homozygous knockout and wild-type mice in a skin carcinogenesis model.
- Assessed tumor formation (benign and malignant).
- Measured oxygen consumption, apoptosis rates, and key metabolite levels (pyruvate, malate, succinate).
Main Results:
- UCP2 knockout significantly reduced the formation of both benign and malignant skin tumors.
- UCP2 knockout did not increase apoptosis during carcinogenesis.
- Oxygen consumption decreased in carcinogen-treated UCP2 knockout mice, while glycolysis increased in carcinogen-treated wild-type mice.
- Distinct metabolite trends were observed between UCP2 knockout and wild-type mice post-carcinogen treatment.
Conclusions:
- This study provides the first in vivo evidence that UCP2 knockout suppresses carcinogenesis.
- UCP2 plays a role in promoting skin cancer development.
- UCP2 represents a potential therapeutic target for cancer prevention and treatment.
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)